You are here

News

Comment

Discuss

Coverage of the latest news and updates from the field of stem cells.

July 9, 2014

About 7 days after conception, something remarkable occurs in the clump of cells that will eventually become a new human being. They start to specialize into any of the roughly 200 cell types that exist in people.

July 8, 2014

Two men with HIV may have been cured after they received stem cell transplants to treat lymphoma, a type of blood cancer.

July 8, 2014

Researchers have identified a way to enhance regrowth of human corneal tissue to restore vision, using a molecule known as ABCB5 that acts as a marker for hard-to-find limbal stem cells.

July 1, 2014

Osiris Therapeutics, Inc., has announced that a report of the results of its multicenter randomized, controlled clinical trial comparing the safety and effectiveness of Grafix to control in patients with chronic diabetic foot ulcers (DFUs) has been accepted for publication in the Internationa

July 1, 2014

Scientists have discovered a new class of lipids in leukemia cells that are detected by a unique group of immune cells. By recognizing the lipids, the immune cells stimulate an immune response to destroy the leukemia cells and suppress their growth.  

July 1, 2014

Calimmune has been given the go ahead to treat a second group of patients in a phase I/II clinical trial testing its gene-based stem cell therapy for HIV.

The company was given the green light to move ahead following a review of safety data by the Data Safety Monitoring Board (DSMB).

June 24, 2014

An EU-funded project called “VascuBone” that is focused on alternative solutions for treating bone defects is heading  full speed into its final months of development.

June 24, 2014

The secret of how salamanders successfully regrow body parts is being unraveled by researchers in a bid to apply it to humans.

June 24, 2014

New research suggests that the diversity of bacteria in the gastrointestinal tract of patients receiving stem cell transplants may be an important predictor of their survival.

June 24, 2014

A multisite phase II clinical trial launched this month in the United States to evaluate the safety and efficacy of a proprietary line of stem cells for treating patients in the early stages of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.  

Pages